United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
317.42
-5.53 (-1.71%)
Mar 18, 2025, 3:13 PM EDT - Market open
United Therapeutics Employees
United Therapeutics had 1,305 employees as of December 31, 2024. The number of employees increased by 137 or 11.73% compared to the previous year.
Employees
1,305
Change (1Y)
137
Growth (1Y)
11.73%
Revenue / Employee
$221,338,462
Profits / Employee
$91,930,769
Market Cap
14.26B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,305 | 137 | 11.73% |
Dec 31, 2023 | 1,168 | 183 | 18.58% |
Dec 31, 2022 | 985 | 20 | 2.07% |
Dec 31, 2021 | 965 | 15 | 1.58% |
Dec 31, 2020 | 950 | 30 | 3.26% |
Dec 31, 2019 | 920 | 60 | 6.98% |
Dec 31, 2018 | 860 | 60 | 7.50% |
Dec 31, 2017 | 800 | 50 | 6.67% |
Dec 31, 2016 | 750 | 0 | - |
Dec 31, 2015 | 750 | 10 | 1.35% |
Dec 31, 2014 | 740 | 34 | 4.82% |
Dec 31, 2013 | 706 | 83 | 13.32% |
Dec 31, 2012 | 623 | 80 | 14.73% |
Dec 31, 2011 | 543 | 23 | 4.42% |
Dec 31, 2010 | 520 | 110 | 26.83% |
Dec 31, 2009 | 410 | 50 | 13.89% |
Dec 31, 2008 | 360 | 40 | 12.50% |
Dec 31, 2007 | 320 | 35 | 12.28% |
Dec 31, 2006 | 285 | 75 | 35.71% |
Dec 31, 2005 | 210 | 40 | 23.53% |
Dec 31, 2004 | 170 | 10 | 6.25% |
Dec 31, 2003 | 160 | 10 | 6.67% |
Dec 31, 2002 | 150 | 22 | 17.19% |
Dec 31, 2001 | 128 | 18 | 16.36% |
Dec 31, 2000 | 110 | 47 | 74.60% |
Dec 31, 1999 | 63 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
UTHR News
- 14 days ago - United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025 - Business Wire
- 20 days ago - United Therapeutics Corporation (UTHR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 20 days ago - United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 21 days ago - United Therapeutics: A Unique Business With High Margins And Expansion Potential - Seeking Alpha
- 22 days ago - United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference - Business Wire
- 27 days ago - United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025 - Business Wire
- 6 weeks ago - United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis - Business Wire
- 6 weeks ago - United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial - Business Wire